Morgan Stanley’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$3 | – | 8098 |
|
|
2025
Q1 | – | Hold |
0
| – | -$3 | – | 8050 |
|
|
2024
Q4 | – | Hold |
0
| – | -$5 | – | 7940 |
|
|
2024
Q3 | – | Hold |
0
| – | -$13 | – | 7886 |
|
|
2024
Q2 | – | Hold |
0
| – | -$33 | – | 7770 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$58 | – | 7603 |
|
|
2023
Q4 | $58 | Buy |
+1
| New | +$58 | ﹤0.01% | 7623 |
|
|
2023
Q3 | – | Hold |
0
| – | -$255 | – | 7432 |
|
|
2023
Q2 | – | Sell |
-2
| Closed | -$1.26K | – | 7434 |
|
|
2023
Q1 | $1.26K | Sell |
2
-3
| -60% | -$1.89K | ﹤0.01% | 7320 |
|
|
2022
Q4 | $3.77K | Buy |
5
+2
| +67% | +$1.51K | ﹤0.01% | 7224 |
|
|
2022
Q3 | $4K | Hold |
3
| – | – | ﹤0.01% | 7286 |
|
|
2022
Q2 | $3K | Hold |
3
| – | – | ﹤0.01% | 7496 |
|
|
2022
Q1 | $5K | Buy |
+3
| New | +$5K | ﹤0.01% | 7570 |
|
|
2021
Q4 | – | Hold |
0
| – | -$1K | – | 7964 |
|
|
2021
Q3 | – | Hold |
0
| – | -$2K | – | 7749 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7515 |
|